🇺🇸 FDA
Patent

US 11214603

C3D cellular and acellular vaccines for the prevention and treatment of cancer

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11214603 (C3D cellular and acellular vaccines for the prevention and treatment of cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/5152, A61K2039/54